VTCN1 and cancer: According to our survival analysis, B7-H4 may act as a prognostic factor for patient with low stromal TIL ovarian serous carcinoma or as a therapeutic target that can suppress cancer stemness but not immune evasion in patients with low stromal TIL/B7-H4-positive ovarian serous carcinoma.